Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)

Date: January 23, 2011
Pages: 21
US$ 259.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)
The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO; IL-11) as of January 2011 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

  • TPO-R Activators
  • IL-11-R Activators
  • Small Molecule TPO Agonists
  • Others
  • Corporate TPO/IL-11 Receptor Agonist R&D Pipelines
  • About La Merie

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Skip to top

Competitor Analysis: Neurotrophic Growth Factors US$ 480.00 Dec, 2009 · 38 pages
Competitor Analysis: Erythropoietin (EPO) US$ 684.00 Jan, 2011 · 76 pages

Ask Your Question

Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: